On December 27, 2017, the majority shareholders of EnzymeBioSystems voted to realign the Officers in the Company by appointing John Dean Harper to the Board of Directors as the sole Director. Subsequently, the Board of Directors accepted the resignation of Gary Rojewski, in his position as Director and Officer of the Company. Mr. Rojewski tendered his resignation to the Company on December 27, 2017.

The Board appointed the company's Corporate Secretary, John Dean Harper, to the positions of President/CEO and Treasurer. The Board further decided to keep Ashot Marirosyan as Chief Scientific Officer and dissolved the position of Interim Accounting Officer, formerly held by John Dean Harper.